The NASA Mars Sample Return program is encountering resistance from the planetary science community due to proposed budget language that would terminate the current mission framework. In early January ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Luxury EVs in China now offer 24-karat gold badges and Porsche-like options — but at half the price. Porsche faces a myriad of problems in China. For one, the brand’s cars are somewhat niche by design ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...

You’ve probably heard of Porsche’s Paint to Sample program that allows customers to spec their car in colors not listed among the stock color swatches. But did you know it’s not just one program, but ...

(RTTNews) - Recursion Pharmaceuticals, Inc. (RXRX), a clinical-stage TechBio company, on Monday, announced that it is deprioritizing three of its clinical programs and one preclinical program ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...